Curapep LLC

Curapep LLC is a biotechnology company specializing in advanced wound and skin care solutions. The company develops science-driven therapies addressing unmet needs in wound healing and dermatological conditions. Curapep's core offering centers on Oxygen Boost Technology, a proprietary platform designed to create a moist, oxygen-rich microenvironment that supports tissue repair and regeneration. The company's flagship product is Vitynex™ Cream, a topical wound care formulation utilizing advanced peptide technology intended for soothing, healing, and regenerating damaged tissue. The company also offers VityPatch™ Hydrogel, an advanced hydrogel dressing engineered to maintain wound moisture while optimizing oxygen diffusion and supporting autolytic debridement. Curapep's development pipeline includes CP-104, a small-molecule therapeutic currently in development targeting diabetic ulcers and chronic wounds. The company targets healthcare professionals, wound care specialists, dermatologists, and institutions managing chronic wounds, pressure ulcers, diabetic foot ulcers, and post-procedural wounds. Founded by Prof. Amor Khachemoune (dermatology and Mohs surgery expert), Dr. Selim (biology and drug/device design specialist), and Dr. Larry Shimp (biomaterials expert with over 30 years' experience), Curapep emphasizes clinical rigor, scientific excellence, and patient-centered outcomes. The company actively recruits distributors nationwide and markets its products through e-commerce channels. Regulatory status and specific FDA clearances are not detailed on the website.